dc.contributor.author |
Krishnamurthi, Rita |
en |
dc.contributor.author |
Mathai, Sam |
en |
dc.contributor.author |
Kim, Hyun Ah |
en |
dc.contributor.author |
Zhang, Rong |
en |
dc.contributor.author |
Guan, Jian |
en |
dc.date.accessioned |
2012-03-15T23:45:33Z |
en |
dc.date.issued |
2009 |
en |
dc.identifier.citation |
BRITISH JOURNAL OF PHARMACOLOGY 156(4):662-672 01 Feb 2009 |
en |
dc.identifier.issn |
0007-1188 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/14499 |
en |
dc.description.abstract |
Cyclo-L-glycyl-L-2-Allylproline (NNZ 2591) , a modified diketppiperazine, is neuroprotective and improves long-term function after hypoxic-ischemic brain injury in rats. The present studies reveal that early treatment with NNZ 2591 protects against the motor deficit induced by 6-OHDA and the tretment initiated after the establishment of motor impairment siginificantly improves long-term motor function. These effects of NNZ 2591 on functional recovery were independent of dopamine depletion and also appeared not to be symptomatic as the improved motor function was long -lasting. NNZ 2591 has potential as a therapeutic agent for neurodegeneratiive disorders |
en |
dc.publisher |
British Pharmacological Society |
en |
dc.relation.ispartofseries |
British Journal of Pharmacology |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://www.sherpa.ac.uk/romeo/issn/0007-1188/ |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.title |
A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA induced motor deficit in rats |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1111/j.1476-5381.2008.00064.x |
en |
pubs.begin-page |
662 |
en |
pubs.volume |
156 |
en |
dc.rights.holder |
Copyright: British Pharmacological Society |
en |
dc.identifier.pmid |
19154439 |
en |
pubs.end-page |
667 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
81422 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
Medical Sciences |
en |
pubs.org-id |
Pharmacology |
en |
pubs.org-id |
Physiology Division |
en |
pubs.record-created-at-source-date |
2010-09-01 |
en |
pubs.dimensions-id |
19154439 |
en |